entertainment -WSS

entertainment

author：entertainment 2025-09-30 12:08:13 - browse：1943

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Plastic surgeons increase patient psychiatric screenings

hotspot

WSS

Plastic surgeons increase patient psychiatric screenings

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Surprise medical billing ban raises prices elsewhere

Readout Newsletter: Bluebird, CVS, Contineum

hotspot

entertainment

entertainment

23andMe had bad news about my health. I wish a person had delivered it

UnitedHealth increases loan offers after Change Healthcare outage

In age of alternative facts, a scholarly course on calling out crap

Abridge raises $150m as clinical notes automation market heats up

Medical leaders decry Supreme Court decision on affirmative action

Creating egg and sperm cells from stem cells raises ethical issues

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Wildfire smoke exposes gaps in outdoor worker protections

Stop the failed accountable care organization experiment

hotspot

Medicare Advantage enrollment hits roughly 33.4 million

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Surprise medical billing ban raises prices elsewhere

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Stop the failed accountable care organization experiment

SCOTUS questions limit to govt efforts to fight misinformation

Wikipedia

hotspot

hotspot

explore